Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-08-13
2009-11-03
Kemmerer, Elizabeth C (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S002600, C514S007600, C514S008100
Reexamination Certificate
active
07612050
ABSTRACT:
A bisphosphonate for the treatment of osteonecrosis and/or osteonecrosis dissecans. The drug may further he used to prevent the onset of osteonecrosis and/or osetonecrosis dissecans and any complications associated with both diseases.
REFERENCES:
patent: 5755809 (1998-05-01), Cohen et al.
patent: 5843678 (1998-12-01), Boyle
patent: 6316408 (2001-11-01), Boyle
patent: 7425549 (2008-09-01), Little et al.
patent: WO0243738 (2002-06-01), None
Fulfaro et al., 1998, Pain 78:157-169.
Podwomy et al., 1999, J. Rheumatol. 26:1972-1982.
Little David Graham
Smith Nicholas Charles
Bozicevic Field & Francis LLP
Francis Carol L.
Kemmerer Elizabeth C
The Royal Alexandra Hospital for Children
LandOfFree
Drug for the treatment of osteonecrosis and for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug for the treatment of osteonecrosis and for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for the treatment of osteonecrosis and for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4143641